HighTower Advisors’s DexCom DXCM Stock Holding History

HighTower Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$4.1K	–	3503
2023 Q1	$4.1K	Buy	+500	New	+$56K	﹤0.01%	3244
2020 Q4	–	Sell	-400	Closed	-$5K	–	2673
2020 Q3	$5K	Buy	+400	New	+$41.8K	﹤0.01%	2460
2018 Q3	–	Sell	-4,000	Closed	-$2K	–	2323
2018 Q2	$2K	Buy	+4,000	New	+$84.8K	﹤0.01%	2195

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HighTower Advisors's DXCM Position: Q1 2026 in Review

HighTower Advisors reduced its DexCom (DXCM) stake by 3% in Q1 2026, selling an estimated $253K and leaving 118,064 shares worth $7.41M. The position accounts for 0.01% of the portfolio, ranked #1009.

HighTower Advisors first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. The position peaked at $18.5M in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

HighTower Advisors held 118,064 shares of DexCom worth $7.41M as of Q1 2026.
HighTower Advisors sold 3,633 DexCom shares in Q1 2026, an estimated $253K.
DexCom made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1009 holding.
HighTower Advisors first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
HighTower Advisors's DexCom position peaked at $18.5M in Q4 2020.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.